Berkeley Lights, Inc.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PhenomeX is enabling researchers to take advantage of each cell's full potential and launch the next phase of functional cell biology that will improve human health. We give researchers the most thorough understanding of how cells function and a detailed picture of each cell's behaviour.

Company outlines near-term strategic plan to generate positive operating cashflow by early 2025 EMERYVILLE, Calif. , Aug. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended June 30, 2022.

Berkeley Lights Reports Second Quarter 2022 Financial Results

EMERYVILLE, Calif. , Aug. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today announced the discovery, functional characterization, and recovery of a patient-derived T cell receptor sequence against a cancer neoantigen.

Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen

Presentation to feature the Company's soon-to-be launched bispecific and custom productivity assay for the Opto® Cell Line Development workflow EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the Cambridge Healthtech Institute's (CHI) 14th Annual Bioprocessing Summit (BPS) being held from August 15 - 18, 2022, virtually and at the Sheraton Boston in Boston, Massachusetts.

Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference

EMERYVILLE, Calif. , Aug. 1, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Rolando Brawer, Ph.D.

Berkeley Lights Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development

Using Berkeley Lights' high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE, Calif. , July 27, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced that the companies have successfully reached their strategic partnership milestone by identifying a commercially viable antimicrobial peptide (AMP) to enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.

Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide

EMERYVILLE, Calif. , July 25, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately.

Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer

EMERYVILLE, Calif. , July 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the second quarter 2022 after market on Tuesday, August 9, 2022.

Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022

Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting

EMERYVILLE, Calif. & ALBANY, N.Y.--(BUSINESS WIRE)-- #AMRI--Curia now provides a comprehensive portfolio of state-of-the-art technologies and experience for rapid progression of client antibody programs.

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Wilmington, Delaware--(Newsfile Corp. - May 31, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Berkeley Lights, Inc. (NASDAQ: BLI) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-berkeley-lights-inc.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Berkeley Lights, Inc.

Berkeley Lights, Inc. (NASDAQ:BLI ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Suzanne Hatcher - Vice President, Communications & Investor Relations Siddhartha Kadia - Chief Executive Officer Paul McClaskey - Chief Accounting Officer Eric Hobbs - President of Antibody Therapeutic Jeff Brown - Vice President of FD&A Conference Call Participants Julia Chen - JP Morgan Brian Weinstein - William Blair Steven Mah - Cowen Gaurav Goparaju - Berenberg Capital Operator Good afternoon. My name is Stephanie And I will be your conference operator today.

Berkeley Lights, Inc. (BLI) CEO Siddhartha Kadia on Q1 2022 Results - Earnings Call Transcript

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -3.23% and 1.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Berkeley Lights, Inc. (BLI) Reports Q1 Loss, Lags Revenue Estimates

EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022.

Berkeley Lights Reports First Quarter 2022 Financial Results

Company's latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification” Company's latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification”

Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo

EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) --  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the appointment of Lucas Vitale to the newly created role of Chief Human Resources Officer (“CHRO”), effective immediately. Vitale will lead Berkeley Lights' Human Resources function. He will report directly to the Company's Chief Executive Officer (CEO), Dr. Siddhartha Kadia. As Berkeley Lights' newly appointed CEO, Dr. Kadia is focused on the further development of its human capital and talent function to support the Company's growth opportunities.

Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer

EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Vestaron Corporation, the leader in peptide-based crop protection, announced a strategic partnership to advance the development of pesticidal peptides as Active Ingredients (AIs) to improve the safety and efficacy of crop protection solutions for the global food supply.

Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service

Occidental Petroleum

ShotSpotter

Although US stock futures traded higher this morning on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain.

Executives Buy More Than $1.5B Of 3 Stocks

EMERYVILLE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) (“Berkeley Lights” or the “Company”) a leader in digital cell biology, today announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer (CEO), effective immediately. Dr. Kadia succeeds Eric D. Hobbs, Ph.D., as part of the previously announced leadership transition. Dr. Kadia will remain a member of the Berkeley Lights Board of Directors.

Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer

EMERYVILLE, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Festival of Biologics meeting, being held from March 9-11, 2022, at the Marriott Marquis San Diego. The Festival of Biologics brings together pharma, biotech and academic and research institutes, as well as their partners across the value chain in the areas of antibodies, immunotherapy and biosimilars.

Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2022 Festival of Biologics Conference

Scientific researchers can now more easily assess cell and assay quality in real-time by selecting the best individual cells for live export Scientific researchers can now more easily assess cell and assay quality in real-time by selecting the best individual cells for live export

Berkeley Lights Releases Upgrade to its Software Suite for Beacon® and Lightning™ Platforms

EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the Cowen 42nd Annual Health Care Conference, taking place virtually March 7-9, 2022.

Berkeley Lights to Participate in Cowen 42nd Annual Health Care Conference

San Diego, California--(Newsfile Corp. - February 27, 2022) - Johnson Fistel, LLP is investigating potential claims on behalf of Berkeley Lights, Inc. ("Berkeley Lights") (NASDAQ: BLI) against certain of its officers and directors.Recently, a class action complaint was filed against Berkeley Lights. The complaint alleges that throughout the Class Period, Defendants made false and misleading statements and failed to disclose that: (1) Berkeley Lights' flagship instrument, the Beacon, suffered from numerous design and manufacturing defects...

Did You Acquire (BLI) Before July 17, 2020? Should Management be Held Accountable for Investors Losses?

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q4 2021 Results - Earnings Call Transcript

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -4% and 5.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Berkeley Lights, Inc. Stock (BLI)